Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

UK and Europe are falling behind US and China in biotech, says AstraZeneca boss

Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China

The Guardian - UK

Shield Therapeutics hails US market progress and mulls stateside listing

The Gateshead company said additional losses were to be expected as it carries out a plan to target US iron deficiency treatment demand

Birmingham Post

The long and winding history of the war on abortion drugs

Along with the stethoscope and camembert cheese, mifepristone may be one of France’s greatest inventions. It’s one of two drugs taken for medical abortions, along with misoprostol, and has been making headlines in the US, where a Texas judge issued a ruling to ban it nationwide. FRANCE 24 takes a…

France 24

From analysis to the latest developments in health,
read the most diverse news in one place.

New CBI boss says she is ‘profoundly sorry’ to women let down by group

Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry

The Guardian - UK

Smith & Nephew reports strong first quarter growth with £44m sales uplift

Hull-founded firm enjoying double digit expansion in largest established market as it awaits consent for East Yorkshire build

Birmingham Post

Regional pharmacists say 60-day medication changes could 'break' overwhelmed system

The extension of dispensing timelines on hundreds of medications will lead to pharmacies closing and impact healthcare access, according to pharmacists in regional NSW.

ABC News

Drug for rare form of Lou Gehrig’s disease OK'd by FDA

U.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

WHO warns of 'extreme biohazard risk' as fighters occupy Sudan's national laboratory

The World Health Organization says that fighters in Sudan have occupied the national public laboratory holding samples of diseases including polio and measles, creating an "extremely, extremely dangerous" situation.

Radio France Internationale

King's Award for export success through Covid for pharma packaging firm launched in Grimsby

ALLpaQ recognised for outstanding international trade after role in US vaccine roll-out

Birmingham Post

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

The Guardian - UK

Canada will try to offer abortion drug mifepristone to American women if it’s banned in the US

Canada’s Families Minister Karina Gould reacted to the US legal battle over mifepristone the day before the US Supreme Court ruling

The Independent UK

US Supreme Court keeps abortion pill fully available for now

WASHINGTON — The U.S. Supreme Court blocked a Texas judge’s restrictions on a widely used abortion pill from taking effect, keeping the drug fully available while a legal fight goes forward.

Tribune News Service

US supreme court blocks ruling limiting access to abortion pill

Federal judge in Texas ruled in early April to suspend FDA-approved mifepristone used in more than half of abortions in US

The Guardian - US

2 Healthcare Stocks Showing Stability With A and B POWR Ratings

The healthcare industry should thrive with accelerated breakthrough developments and a growing market for telemedicine and personalized medicines. Moreover, given the lingering macroeconomic headwinds, fundamentally strong healthcare stocks, Amgen (AMGN), and Otsuka Holdings (OTSKY) showing Stability with A and B POWR Ratings could be ideal buys. Read more.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Top 3 Stocks to Sell in April With Weak Fundamentals

The biopharmaceutical industry has been grappling with various challenges, including inflation, the Fed’s hawkish stance, and new regulatory concerns. Hence, it could be wise to avoid Syndax Pharmaceuticals (SNDX), Senseonics Holdings (SENS), and Sio Gene Therapies (SIOX) due to their bleak fundamentals. Keep reading….

StockNews.com

Stay Away From These 3 Stocks With Bearish Momentum in April

Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals (DAWN), Northwest Biotherapeutics (NWBO), and Ocugen (OCGN), with bearish momentum, could be avoided in April. Read on….

Tribune News Service

Supreme Court delays decision in abortion drug case

WASHINGTON — The Supreme Court gave itself more time on a decision expected Wednesday about a commonly used abortion drug, extending until Friday a temporary pause on a lower court ruling that would restrict availability of mifepristone.

Tribune News Service

Generic abortion pill maker sues FDA to protect access

A generic-mifepristone maker sued the U.S. Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington.

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

Supreme Court temporarily extends access to abortion pill

The court has given itself until Friday to rule on whether to allow restrictions to take effect on mifepristone as legal challenges to its FDA approval continue.

WEKU

Generic abortion pill manufacturer sues FDA in effort to preserve access

GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.

The National (Scotland)

Trade unions to urge Labour to make manifesto commitment to devolving drug law

TRADE Unions have agreed to urge Labour to include a commitment to devolve drug powers to Scotland in their next General Election manifesto.

Tribune News Service

The drug company that prospered without creating any drugs

The new drug looked so promising — except for that one warning sign.

Tribune News Service

Abortion foes urge Supreme Court to curb pill on eve of deadline

Abortion opponents urged the U.S. Supreme Court to allow new restrictions on a widely used pill to end pregnancy, presenting the justices with a stark choice on one of the country’s most divisive issues.

StockNews.com

Why Insiders Are Aggressively Buying This Under $1 Stock

While insiders are showing significant interest in penny stock Processa Pharmaceuticals (PCSA), the stock has witnessed a weak momentum over the past year. Let’s take a look at its key metrics to understand if there is any hope for sustainable share price appreciation. Read on.

Al Jazeera

Anti-abortion groups urge US top court to restrict abortion pill

Groups push the US Supreme Court to reject Biden administration request to halt a Texas ruling limiting access to pill.

1 … 53 54 55 56

People

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

the Justice Department

World Health Organization

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.